Stéphanie Baggio
Clinical trials sponsored by Stéphanie Baggio, explained in plain language.
-
Prison ADHD drug trial aims to cut recidivism
Disease control Recruiting nowThis study tests whether a common ADHD medication (OROS-methylphenidate) can help prisoners with ADHD manage their symptoms and reduce problem behaviors. About 150 adults in French prisons will receive either the drug or a placebo for several months. Researchers will track change…
Phase: PHASE3 • Sponsor: Stéphanie Baggio • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New method aims to help prisoners understand research consent
Knowledge-focused Recruiting nowThis study tests a new method to help prisoners better understand what they are agreeing to when joining a research study. Researchers will compare an enhanced 'teach-to-goal' consent process with the standard one in 100 adults with ADHD in prison. The goal is to improve ethical …
Phase: NA • Sponsor: Stéphanie Baggio • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC